Proposed INN |
Chemical name or description: Action and use: Molecular formula |
(Latin, English, French, Spanish) |
Chemical Abstracts Service (CAS) registry number: Graphic formula |
| |
|
DCI Proposée |
Nom chimique ou description: Propriétés et indications: Formule brute |
| |
Numéro dans le registre du CAS: Formule développée |
| |
|
DCI Propuesta |
Nombre químico o descripción: Acción y uso: Fórmula empírica |
| |
Número de registro del CAS: Fórmula desarrollada |
acidum gadocoleticum |
|
gadocoletic acid |
trihydrogen [3β-[[(4S)-4-[bis[2-[bis[(carboxy-κN)methyl]amino-κN]ethyl]amino-κN]-4-(carboxy-κO)butanoyl]amino]-12α-hydroxy-5β-cholan-24-oato(6-)] = gadolinate(3-)
diagnostic agent |
acide gadocolétique |
trihydrogéno[3β-[[(4S)-4-[bis[2-[bis[(carboxy-κO)méthyl]amino-κN]éthyl]amino-κN]-4-(carboxy-κO)butanoyl]amino]-12α-hydroxy-5β-cholan-24-oato(6-)] = gadolinate(3-)
produit á usage diagnostique |
ácido gadocolético |
trihidrógeno[3β-[[(4S)-4-[bis[2-[bis[(carboxi-κO)metil]amino-κN]etil]amino-κN]-4-(carboxi-κO)butanoil]amino]-12α-hidroxi-5β-colan-24-oato(6-)]gadolinato(3-)
agente de diagnóstico |
| |
C41H63GdN4O14 |
| |
|
afeletecanum |
|
afeletecan |
camptothecin, ester with N-[[p-[(3-O-methyl-â-L-fucopyranosyl)oxy]phenyl] = thiocarbamoyl]-L-histidyl-L-valine
antineoplastic |
afélétécan |
(2S)-2-[[(2S)-3-(1H-imidazol-4-yl)-2-[[[[4-[(3-O-méthyl-6-désoxy-â-L-galactopyranosyl)oxy]phényl]amino]thiocarbonyl]amino]propanoyl]amino]-3-méthylbutanoate de (4S)-4-éthyl-3,14-dioxo-3,4,12,14-tétrahydro-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoléin-4-yle antinéoplasique |
afeletecán |
éster de la camptotecina con N-[[p-[(3-O-metil-â-L-fucopiranosil)oxi]fenil] = tiocarbamoil]-L-histidil-L-valina
antineoplásico |
| |
C45H49N7O11S |
215604-75-4 |
| |
|
alfimeprasum |
|
alfimeprase |
[3-L-serine]fibrolase-(3-203)-peptide (fibrolase: fibrinolytic enzyme isolated from Agkistrodon contrix contrix venom)
antithrombotic |
alfiméprase |
[3-L-sérine]fibrolase-(3-203)-peptide (fibrolase: enzyme fibrinolytique extraite de venin d’Agkistrodon contrix contrix)
antithrombotique |
alfimeprasa |
[3-L-serina]fibrolasa-(3-203)-péptido (fibrolasa: enzime fibrinolítica extraida de veneno de Agkistrodon contrix contrix)
antithrombótico |
| |
C985H1541N285O301S12 |
259074-76-5 |
| |
|
alicaforsenum |
|
alicaforsen |
2’-deoxy-(R)-P-thioguanylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-deoxy-(R)-P-thioadenylyl-(3’→5’)-2’-deoxy-(R)-P-thioadenylyl-(3’→5’)-2’-deoxy-(R)-P-thioguanylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-(R)-P-thiothymidylyl-(3’→5’)-2’-deoxy-(R)-P-thioguanylyl-(3’→5’)-2’-deoxy-(R)-P-thioguanylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-deoxy-(R)-P-thioadenylyl-(3’→5’)-(R)-P-thiothymidylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-deoxy-(R)-P-thioguanylyl-(3’→5’)-(R)-P-thiothymidylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-deoxyadenosine nonadecasodium salt
antisense phosphorotioate oligonucleotide |
alicaforsen |
2’-désoxy-(R)-P-thioguanylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-désoxy-(R)-P-thioadénylyl-(3’→5’)-2’-désoxy-(R)-P-thioadénylyl-(3’→5’)-2’-désoxy-(R)-P-thioguanylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-(R)-P-thiothymidylyl-(3’→5’)-2’-désoxy-(R)-P-thioguanylyl-(3’→5’)-2’-désoxy-(R)-P-thioguanylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-désoxy-(R)-P-thioadénylyl-(3’→5’)-(R)-P-thiothymidylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-désoxy-(R)-P-thioguanylyl-(3’→5’)-(R)-P-thiothymidylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-désoxyadénosine nonadécasodique
inhibiteur de la synthèse de la protéine d’adhésion ICAM-1 |
alicaforseno |
2’-desoxi-(R)-P-tioguanilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-2’-desoxi-(R)-P-tioadenilil-(3’→5’)-2’-desoxi-(R)-P-tioadenilil-(3’→5’)-2’-desoxi-(R)-P-tioguanilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-(R)-P-tiotimidilil-(3’→5’)-2’-desoxi-(R)-P-tioguanilil-(3’→5’)-2’-desoxi-(R)-P-tioguanilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-2’-desoxi-(R)-P-tioadenilil-(3’→5’)-(R)-P-tiotimidilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-2’-desoxi-(R)-P-tioguanilil-(3’→5’)-(R)-P-tiotimidilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-2’-desoxiadenosina nonadecasódica
cadena complementaria (oligonucleótido fosforotioato) |
| |
C192H225N75Na19O98P19S19 |
185229-68-9 |
alilusemum |
|
alilusem |
7-chloro-1-(2-methylbenzoyl)-2,3-dihydroquinolin-4(1H)-one (E)-O-sulfooxime
diuretic |
alilusem |
(E)-O-sulfooxime de 7-chloro-1-(2-méthylbenzoyl)-2,3-dihydroquinoléin-4(1H)-one |
| |
diurétique |
alilusem |
(E)-O-sulfooxima de 7-cloro-1-(2-metilbenzoil)-2,3-dihidroquinolin-4(1H)-ona |
| |
diurético |
| |
C17H15ClN2O5S |
144506-11-6 |
ambrisentanum |
|
ambrisentan |
(+)-(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid
endothelin receptor antagonist |
ambrisentan |
(+)-acide (2S)-2-[(4,6-diméthylpyrimidin-2-yl)oxy]-3-méthoxy-3,3-diphénylpropanoïque antagoniste du récepteur de l’endothéline |
ambrisentán |
(+)-ácido (2S)-2-[(4,6-dimetilpirimidin-2-il)oxi]-3-metoxi-3,3-difenilpropanoico
antagonista del receptor de endotelina |
| |
C22H22N2O4 |
177036-94-1 |
| |
|
| |
|
amdoxovirum |
|
amdoxovir |
[(2R,4R)-4-(2,6-diamino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol
antiviral |
amdoxovir |
[(2R,4R)-4-(2,6-diamino-9H-purin-9-yl)-1,3-dioxolan-2-yl]méthanol
antiviral |
amdoxovir |
[(2R,4R)-4-(2,6-diamino-9H-purin-9-il)-1,3-dioxolan-2-il]metanol
antiviral |
| |
C9H12N6O3 |
145514-04-1 |
| |
|
amelubantum |
|
amelubant |
ethyl [[4-[[3-[[4-[1-(4-hydroxyphenyl)-1-methylethyl]phenoxy]methyl]benzyl] = oxy]phenyl](imino)methyl]carbamate
leukotriene receptor antagonist |
amélubant |
[[4-[[3-[[4-[1-(4-hydroxyphényl)-1-méthyléthyl]phénoxy]méthyl]benzyl]oxy] = phényl](imino)méthyl]carbamate d’éthyle
antagoniste du récepteur des leucotriènes |
amelubant |
[[4-[[3-[[4-[1-(4-hidroxifenil)-1-metiletil]fenoxi]metil]bencil]oxi]fenil](imino)metil] = carbamato de etilo
antagonista del receptor de leucotrienos |
| |
C33H34N2O5 |
| |
|
amotosalenum |
|
amotosalen |
3-[(2-aminoethoxy)methyl]-2,5,9-trimethyl-7H-furo[3,2-g][1]benzopyran-7-one
photochemical therapy |
amotosalène |
3-[(2-aminoéthoxy)méthyl]-2,5,9-triméthyl-7H-furo[3,2-g][1]benzopyran-7-one
photochimiothérapie |
amotosaleno |
3-[(2-aminoetoxi)metil]-2,5,9-trimetil-7H-furo[3,2-g][1]benzopiran-7-ona
terapia fotoquímica |
| |
C17H19NO4 |
161262-29-9 |
| |
|
bimatoprostum |
|
bimatoprost |
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-N-ethyl-5-heptenamide
antiglaucoma |
bimatoprost |
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phénylpent-1-ényl]cyclopentyl]-N-éthylhept-5-énamide
antiglaucomateux |
bimatoprost |
(Z)-7-[(1R,2R,3R,5S)-3,5-dihidroxi-2-[(1E,3S)-3-hidroxi-5-fenilpent-1-enil]ciclopentil]-N-etilhept-5-enamida
antiglaucoma |
| |
C25H37NO4 |
155206-00-1 |
| |
|
caldaretum |
|
caldaret |
5-methyl-2-(piperazin-1-yl)benzenesulfonic acid
cardiac stimulant |
caldaret |
acide 5-méthyl-2-(pipérazin-1-yl)benzènesulfonique
cardiotonique |
caldaret |
ácido 5-metil-2-(piperazin-1-il)bencenosulfónico
cardiotónico |
| |
C11H16N2O3S |
133804-44-1 |
| |
|
cipralisantum |
|
cipralisant |
4-[(1R,2R)-2-(5,5-dimethylhex-1-ynyl)cyclopropyl]-1H-imidazole histamine-H3 receptor antagonist |
cipralisant |
4-[(1R,2R)-2-(5,5-diméthylhex-1-ynyl)cyclopropyl]-1H-imidazole antagoniste des récepteurs H3 de l’histamine |
cipralisant |
4-[(1R,2R)-2-(5,5-dimetilhex-1-inil)ciclopropil]-1H-imidazol antagonista de los receptores H3 de la histamina |
| |
C14H20N2 |
213027-19-1 |
| |
|
dalbavancinum |
|
dalbavancin |
5,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-O-[2-deoxy-2-[(10-methylundecanoyl)amino]-b-d-glucopyranuronosyl]-38-[[3-(dimethylamino)propyl]carbamoyl]-42-O-a-d-mannopyranosyl-15-N-methyl(ristomycin A aglicone)
antibiotic |
dalbavancine |
acide 2-désoxy-1-O-[(3S,15R,18R,34R,35S,38S,48R,50aR)-5,31-dichloro-38-[[3-(diméthylamino)propyl]carbamoyl]-6,11,34,40,44-pentahydroxy-42-(a-d-mannopyranosyloxy)-15-(méthylamino)-2,16,36,50,51,59-hexaoxo-2,3,16,17,18,19,35,36,37,38,48,49,50,50a-tétradécahydro-20,23:30,33-diéthéno-3,18:35,48-bis(iminométhano)-1H,15H-4,8:10,14:25,28:43,47-tétraméthéno-34H-[1,14,6,22]dioxadiazacyclooctacosino[4,5-m][10,2,16]benzoxadiazacyclotétracosén-56-yl]-2-[(10-méthylundécanoyl)amino]-b-d-glucopyranuronique
antibiotique |
dalbavancina |
ácido 1-O-[(3S,15R,18R,34R,35S,38S,48R,50aR)-5,31-dicloro-38-[[3-(dimetilamino)propil]carbamoil]-6,11,34,40,44-pentahidroxi-42-(α-D-manopiranosiloxi)-15-(metilamino)-2,16,36,50,51,59-hexaoxo-2,3,16,17,18,19,35,36,37,38,48,49,50,50a-tetradecahidro-20,23:30,33-dieteno-3,18:35,48-bis(iminometano)-1H,15H-4,8:10,14:25,28:43,47-tetrameteno-34H-[1,14,6,22]dioxadiazaciclooctacosino[4,5-m][10,2,16] = benzoxadiazaciclotetracosen-56-il]-2-[(10-metilundecanoil)amino]-2-desoxi-β-D-glucopiranurónico antibiótico |
| |
C88H100Cl2N10O28 |
171500-79-1 |
| |
|
darbepoetinum alfa |
|
darbepoetin alfa |
[30-L-asparagine,32-L-thronine,87-L-valine,88-L-asparagine, 90-L-threonine]erythropoietin (human)
antianaemic |
darbépoétine alfa |
[30-L-asparagine,32-L-thréonine,87-L-valine,88-L-asparagine, 90-L-thréonine]érythropoiétine humaine
antianémique |
darbepoetina alfa |
[30-L-asparagina,32-L-treonina,87-L-valina,88-L-asparagina, 90-L-treonina]eritropoietina humana
antianémico |
| |
C800H1300N228O243S5 |
209810-58-2 |
| |
|
drotrecoginum alfa |
|
drotrecogin alfa |
blood coagulation factor XIV (human)
anticoagulant |
drotrécogine alfa |
facteur XIV humain de coagulation sanguine
anticoagulant |
drotrecogina alfa |
factor XIV de coagulación sanguínea (humano)
anticoagulante |
| |
C2071H3165N581O640S31 |
98530-76-8 |
| |
|
ecalcidenum |
|
ecalcidene |
1-[(5Z,7E,20S)-1α,3β-dihydroxy-9,10-secochola-5,7,10(19)-trien-24-oyl]piperidine
antipsoriatic |
écalcidène |
1-[(5Z,7E,20S)-1α,3β-dihydroxy-9,10-sécochola-5,7,10(19)-trién-24-oyl]pipéridine
antipsoriasique |
ecalcideno |
1-[(5Z,7E,20S)-1α,3β-dihidroxi-9,10-secocola-5,7,10(19)-trien-24-oil]piperidina
antipsoriásico |
| |
C29H45NO3 |
150337-94-3 |
| |
|
efalizumabum |
|
efalizumab |
immunoglobulin G1, anti-(human antigen CD11a) (human-mouse monoclonal hu1124 γ1-chain), disulfide with human-mouse monoclonal hu1124 light chain, dimer
immunomodulator |
éfalizumab |
immunoglobuline G1, anti-(antigène CD11a humain) (chaîne γ 1 de l’anticorps moclonal de souris humanisé hu1124), dimère du disulfure avec la chaîne légère de l’anticorps moclonal de souris humanisé hu1124
immunomodulateur |
efalizumab |
inmunoglobulina G1, anti-(antígeno CD11a humano) (cadena γ 1 del anticuerpo monoclonal humanizado de ratón hu1124), dímero del disulfuro con la cadena ligera del anticuerpo monoclonal humanizado de ratón hu1124
inmunomodulador |
| |
214745-43-4 |
enfuvirtidum |
|
enfuvirtide |
acetyl-L-tyrosyl-L-threonyl-L-seryl-L-leucyl-L-isoleucyl-L-histidyl-L-seryl-L-leucyl-L-isoleucyl-L-α-glutamyl-L-α-glutamyl-L-seryl-L-glutaminyl-L-asparaginyl-L-glutaminyl-L-glutaminyl-L-α-glutamyl-L-lysyl-L-asparaginyl-L-α-glutamyl-L-glutaminyl-L-α-glutamyl-L-leucyl-L-leucyl-L-α-glutamyl-L-leucyl-L-α-aspartyl-L-lysyl-L-tryptophyl-L-alanyl-L-seryl-L-leucyl-L-tryptophyl-L-asparaginyl-L-tryptophyl-L-phenylalaninamide
antiviral |
enfuvirtide |
acétyl-L-tyrosyl-L-thréonyl-L-séryl-L-leucyl-L-isoleucyl-L-histidyl-L-séryl-L-leucyl-L-isoleucyl-L-α-glutamyl-L-α-glutamyl-L-séryl-L-glutaminyl-L-asparaginyl-L-glutaminyl-L-glutaminyl-L-α-glutamyl-L-lysyl-L-asparaginyl-L-α-glutamyl-L-glutaminyl-L-α-glutamyl-L-leucyl-L-leucyl-L-α-glutamyl-L-leucyl-L-α-aspartyl-L-lysyl-L-tryptophyl-L-alanyl-L-séryl-L-leucyl-L-tryptophyl-L-asparaginyl-L-tryptophyl-L-phénylalaninamide
antiviral |
enfuvirtida |
acetil-L-tirosil-L-treonil-L-seril-L-leucil-L-isoleucil-L-histidil-L-seril-L-leucil-L-isoleucil-L-α-glutamil-L-α-glutamil-L-seril-L-glutaminil-L-asparaginil-L-glutaminil-L-glutaminil-L-α-glutamil-L-lisil-L-asparaginil-L-α-glutamil-L-glutaminil-L-α-glutamil-L-leucil-L-leucil-L-α-glutamil-L-leucil-L-α-aspartil-L-lisil-L-triptofil-L-alanil-L-seril-L-leucil-L-triptofil-L-asparaginil-L-triptofil-L-fenilalaninamida
antiviral |
| |
C204H301N51O64 |
159519-65-0 |
| |
|
epafipasum |
|
epafipase |
2-acetyl-1-alkyl-sn-glycero-3-phosphocholine deacetylase-(6-400)-peptide(human)
antiallergic, antiasthmatic |
épafipase |
désacétylase-(6-400)-peptide (humaine) de la 2-acétyl-1-alkyl-sn-glycéro-3-phosphocholine
antiallergique, antiasthmatique |
epafipasa |
1-O-alquil-2-acetil-sn-glicero-3-fosfocolina 6-400-desacetilasa (humana)
antialérgico, antiasmático |
| |
C2016H3107N545O586S14 |
208576-22-1 |
| |
|
epoetinum delta |
|
epoetin delta |
1-165-erythropoietin (human HMR4396), glycoform δ
antianaemic |
époétine delta |
1-165-érythropoiétine (humaine HMR4396), glycoforme δ
antianémique |
epoetina delta |
1-165-eritropoietina (humana HMR4396), glicoforma δ
antianémico |
| |
C809H1301N229O240S5 |
261356-80-3 |
| |
|
erlosamidum |
|
erlosamide |
(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide
anticonvulsant |
erlosamide |
(2R)-2-(acétylamino)-N-benzyl-3-méthoxypropanamide
anticonvulsivant |
erlosamida |
(2R)-2-(acetilamino)-N-bencil-3-metoxipropanamida
anticonvulsivo |
| |
C13H18N2O3 |
175481-36-4 |
| |
|
erlotinibum |
|
erlotinib |
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
antineoplastic |
erlotinib |
N-(3-éthynylphényl)-6,7-bis(2-méthoxyéthoxy)quinazolin-4-amine
antinéoplasique |
erlotinib |
N-(3-etinilfenil)-6,7-bis(2-metoxietoxi)quinazolin-4-amina
antineoplásico |
| |
C22H23N3O4 |
183321-74-6 |
| |
|
febuxostatum |
|
febuxostat |
2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid
xanthine oxidase and xanthine dehydrogenase inhibitor |
febuxostat |
acide 2-[3-cyano-4-(2-méthylpropoxy)phényl]-4-méthylthiazole-5-carboxylique
inhibiteur de la xanthine oxydase et de la xanthine déshydrogénase |
febuxostat |
ácido 2-[3-ciano-4-(2-metilpropoxi)fenil]-4-metiltiazol-5-carboxílico
inhibidor de la oxidasa de xantina y la deshidrogenasa de xantina |
| |
C16H16N2O3S |
144060-53-7 |
| |
|
feloprentanum |
|
feloprentan |
(2S)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3,3-diphenylpropanoic acid
endothelin receptor antagonist |
féloprentan |
acide (2S)-3-[2-(3,4-diméthoxyphényl)éthoxy]-2-[(4,6-diméthylpyrimidin-2-yl)oxy]-3,3-diphénylpropanoïque
antagoniste du récepteur de l’endothéline |
feloprentán |
ácido (2S)-3-[2-(3,4-dimetoxifenil)etoxi]-2-[(4,6-dimetilpirimidin-2-il)oxi]-3,3-difenilpropanoico
antagonista del receptor de endotelina |
| |
C31H32N2O6 |
204267-33-4 |
| |
|
finafloxacinum |
|
finafloxacin |
(-)-8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylc acid
antibacterial |
finafloxacine |
(-)-acide 8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl)-4-oxo-1,4-dihydroquinoléine-3-carboxylique
antibactérien |
finafloxacina |
(-)-ácido 8-ciano-1-ciclopropil-6-fluoro-7-[(4aS,7aS)-hexahidropirrolo[3,4-b]-1,4-oxazin-6(2H)-il)-4-oxo-1,4-dihidroquinolina-3-carboxílico
antibacteriano |
| |
C20H19FN4O4 |
209342-40-5 |
| |
|
gadomelitolum |
|
gadomelitol |
hydrogen [2,2’,2’’,2’’’’-[1,4,7,10-tetraazacyclododecane-1,4,7,10-triyl]tetrakis = [5-[[2-[[4-[[4-[[2-[[3,5-bis[bis[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl-2,4,6-tribromo]carbamoyl]phenyl]amino]-2-oxoethyl]carbamoyl]phenyl] = carbamoyl]phenyl]amino]-2-oxoethyl]amino]-5-oxopentanoato](4-)] = gadolinate(1-)
diagnostic agent |
gadomélitol |
hydrogéno-[2,2’,2’’,2’’’-[1,4,7,10-tétraazacyclododécane-1,4,7,10-triyl]tétrakis[5-[[2-[[4-[[4-[[2-[[3,5-bis[bis[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl-2,4,6-tribromo]carbamoyl]phényl]amino]-2-oxoéthyl]carbamoyl]phényl] = carbamoyl]phényl]amino]-2-oxoéthyl]amino]-5-oxopentanoato](4-)] = gadolinate(1-)
produit á usage diagnostique |
gadomelitol |
hidrógeno-[2,2’,2’’,2’’’-[1,4,7,10-tetraazaciclododecano-1,4,7,10-triil]tetrakis = [5-[[2-[[4-[[4-[[2-[[3,5-bis[bis[(2S,3R,4R,5R)-2,3,4,5,6-pentahidroxihexil-2,4,6-tribromo]carbamoil]fenil]amino]-2-oxoetil]carbamoil]fenil]carbamoil]fenil] = amino]-2-oxoetil]amino]-5-oxopentanoato](4-)]gadolinato(1-)
agente de diagnóstico |
| |
C228H313Br12GdN32O116 |
| |
|
garnocestimum |
|
garnocestim |
5-73-macrophage inflammatory protein 2α (human gene gro2)
immunomodulator |
garnocestim |
CXC chimiokine GROβ-(5-73)-peptide (GROβ: protéine inflammatoire humaine sécrétée par les macrophages)
immunomodulateur |
garnocestim |
CXC quimiokina GROβ-(5-73)-péptido (GROβ: proteíne inflamatoria humana secretada por los macrófagos)
inmunomodulador |
| |
C325H557N97O95S6 |
246861-96-1 |
| |
|
gefitinibum |
|
gefitinib |
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine
antineoplastic |
géfitinib |
N-(3-chloro-4-fluorophényl)-7-méthoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine
antinéoplasique |
gefitinib |
N-(3-cloro-4-fluorofenil)-7-metoxi-6-[3-(morfolin-4-il)propoxi]quinazolin-4-amina |
| |
antineoplásico |
| |
C22H24ClFN4O3 |
184475-35-2 |
| |
|
ingliforibum |
|
ingliforib |
5-chloro-N-[(1S,2R)-1-benzyl-3-(cis-3,4-dihydroxypyrrolidin-1-yl)-2-hydroxy-3-oxopropyl]-1H-indole-2-carboxamide
antidiabetic |
ingliforib |
5-chloro-N-[(1S,2R)-1-benzyl-3-(cis-3,4-dihydroxypyrrolidin-1-yl)-2-hydroxy-3-oxopropyl]-1H-indole-2-carboxamide
antidiabétique |
ingliforib |
5-cloro-N-[(1S,2R)-1-bencil-3-(cis-3,4-dihidroxipirrolidin-1-il)-2-hidroxi-3-oxopropil]-1H-indol-2-carboxamida
antidiabético |
| |
C23H24ClN3O5 |
186392-65-4 |
| |
|
ipravacainum |
|
ipravacaine |
(2RS)-1-(cyclopropylmethyl)-2’,6’-dimethyl-2-piperidinecarboxanilide
local anaesthetic |
ipravacaïne |
(2RS)-1-(cyclopropylméthyl)-N-(2,6-diméthylphényl)pipéridine-2-carboxamide
anesthésique local |
ipravacaína |
(2RS)-1-(ciclopropilmetil)-N-(2,6-dimetilfenil)piperidina-2-carboxamida
anestésico local |
| |
C18H26N2O |
166181-63-1 |
| |
|
isegananum |
|
iseganan |
L-arginylglycylglycyl-L-leucyl-L-cysteinyl-L-tyrosyl-L-cysteinyl-L-arginylglycyl-L-arginyl-L-phenylalanyl-L-cysteinyl-L-valyl-L-cysteinyl-L-valylglycyl-L-argininamide cyclic (5→14),(7→12)-bis(disulfide)
antibacterial |
iséganan |
(5→14),(7→12)-bis(disulfure cyclique) de L-arginyl-glycyl-glycyl-L-leucyl-L-cystéinyl-L-tyrosyl-L-cystéinyl-L-arginyl-glycyl-L-arginyl-L-phénylalanyl-L-cystéinyl-L-valyl-L-cystéinyl-L-valyl-glycyl-L-argininamide
antibactérien |
iseganán |
(5→14),(7→12)-bis(disulfuro cíclico) de L-arginil-glicil-glicil-L-leucil-L-cisteinil-L-tirosil-L-cisteinil-L-arginil-glicil-L-arginil-L-fenilalanil-L-cisteinil-L-valil-L-cisteinil-L-valil-glicil-L-argininamida
antibacteriano |
| |
C78H126N30O18S4 |
257277-05-7 |
| |
|
labetuzumabum |
|
labetuzumab |
immunoglobulin G, anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 γ-chain), disulfide with human-mouse monoclonal hMN-14 κ-chain, dimer
immunomodulator |
labétuzumab |
immunoglobuline G, anti-(antigène carcinoembryonnaire humain) (chaîne-γ de l’anticorps monoclonal de souris humanisé hMN-14), dimère du disulfure avec la chaîne-κ de l’anticorps monoclonal de souris humanisé hMN-14
immunomodulateur |
labetuzumab |
inmunoglobulina G, anti-(antígeno carcinoembrionario humano) (cadena-γ del anticuerpo monoclonal humanizado de ratón hMN-14), dímero del disulfuro con la cadena-κ del anticuerpo monoclonal humanizado de ratón hMN-14
inmunomodulador |
| |
219649-07-7 |
laniquidarum |
|
laniquidar |
methyl 6,11-dihydro-11-[1-[2-[4-(-2-quinolylmethoxy)phenyl]ethyl]-4-piperidinylidene]-5H-imidazo[2,1-b][3]benzazepine-3-carboxylate
antineoplastic |
laniquidar |
11-[1-[2-[4-(quinoléin-2-ylméthoxy)phényl]éthyl]pipéridin-4-ylidène]-6,11-dihydro-5H-imidazo[2,1-b][3]benzazépine-3-carboxylate de méthyle
antinéoplasique |
laniquidar |
11-[1-[2-[4-(quinolin-2-ilmetoxi)fenil]etil]piperidin-4-ilideno]-6,11-dihidro-5H-imidazo[2,1-b][3]benzazepina-3-carboxilato de metilo
antineoplásico |
| |
C37H36N4O3 |
197509-46-9 |
| |
|
lapisteridum |
|
lapisteride |
N-[1-(4-methoxyphenyl)-1-methylethyl]-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide
5á-reductase inhibitor |
lapistéride |
3-(1-benzylpipéridin-4-yl)-1-(2,3,4,5-tétrahydro-1H-1-benzazépin-8-yl)propan-1-one
inhibiteur de la 5á-réductase |
lapisterida |
3-(1-bencilpiperidin-4-il)-1-(2,3,4,5-tetrahidro-1H-1-benzazepin-8-il)propan-1-ona
inhibidor de la 5á-reductasa |
| |
C29H40N2O3 |
142139-60-4 |
| |
|
laquinimodum |
|
laquinimod |
5-chloro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide
immunomodulator |
laquinimod |
5-chloro-N-éthyl-4-hydroxy-1-méthyl-2-oxo-N-phényl-1,2-dihydroquinoléine-3-carboxamide
immunomodulateur |
laquinimod |
5-cloro-N-etil-4-hidroxi-1-metil-2-oxo-N-fenil-1,2-dihidroquinolina-3-carboxamida
inmunomodulador |
| |
C19H17ClN0O3 |
248281-84-7 |
| |
|
laronidasum |
|
laronidase |
8-L-histidine-a-L-iduronidase (human)
enzyme |
laronidase |
[8-L-histidine]-a-L-iduronidase humaine
enzyme |
laronidasa |
8-L-histidina-a-L-iduronidasa (humano)
enzima |
| |
C3169H4854N901O884S12 |
210589-09-6 |
| |
|
lirimilastum |
|
lirimilast |
2-(2,4-dichlorobenzoyl)-3-ureidobenzofuran-6-yl methanesulfonate
antiasthmatic |
lirimilast |
méthanesulfonate de 2-(2,4-dichlorobenzoyl)-3-uréidobenzofuran-6-yle
antiasthmatique |
lirimilast |
metanesulfonato de 2-(2,4-diclorobenzoil)-3-ureidobenzofuran-6-ilo
antiasmático |
| |
C17H12Cl2N2O6S |
| |
|
livaraparinum calcium |
|
livaraparin calcium |
calcium salt of a low molecular mass heparin that is obtained by nitrous aciddepolymerization of heparin from porcine intestinal mucosa; the majority of the components have a 2-O-sulfo-α-L-idopyranosuronic acid structure at thenon-reducing end and a 6-O-sulfo-structure at the reducing end of their chain; the mass-average molecular mass ranges between 3000 and 5000 with 75% is less than 8000; the degree of sulfatation is approximately 2 per disaccharidic unit
anticoagulant |
livaraparine calcique |
sel calcique d’une héparine de basse masse moléculaire obtenue par dépolymérisation, au moyen d’acide nitreux, d’héparine de muqueuse intestinale de porc; la majorité des composants de la livaraparine calcique possèdent une structure acide 2-O-sulfo-α-L-idopyranosuronique à l’extrémité non réductrice de leur chaîne et une structure 6-O-sulfatée à l’extrémité réductrice de leur chaîne; la masse moléculaire relative moyenne est de 3000 à 5000, 75% étant inférieur à 8000; le degré de sulfatation par unité disaccharide est voisin de 2
anticoagulant |
livaraparina cálcica |
sal cálcica de una heparina de baja masa molecular obtenida de heparina demucosa intestinal de cerdo por despolimerización con ácido nitroso; la mayoría de los componentes de la livaraparina cálcica tienen ácido 2-O-sulfo-α-L-idopiranosurónico en el extremo no reductor de la cadena y una estructura 6-O-sulfatada en el extremo reductor de la cadena; la masa molecular relativa me dia es de 3000 a 5000, siendo el 75% inferior a 8000; el grado de sulfatación por unidad de disacárido es aproximadamente 2
anticoagulante |
manifaxinum |
|
manifaxine |
(2S,3S,5R)-2-(3,5-difluorophenyl)-3,5-dimethylmorpholin-2-ol
antidepressant |
manifaxine |
(2S,3S,5R)-2-(3,5-difluorophényl)-3,5-diméthylmorpholin-2-ol
antidépresseur |
manifaxina |
(2S,3S,5R)-2-(3,5-difluorofenil)-3,5-dimetilmorfolin-2-ol
antidepresivo |
| |
C12H15F2NO2 |
135306-39-7 |
| |
|
miglustatum |
|
miglustat |
(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
glucosyltransferase inhibitor |
miglustat |
(2R,3R,4R,5S)-1-butyl-2-(hydroxyméthyl)pipéridine-3,4,5-triol
inhibiteur de la glucosyltransférase |
miglustat |
(2R,3R,4R,5S)-1-butil-2-(hidroximetil)piperidina-3,4,5-triol
inhibidor de la glucosil transferasa |
| |
C10H21NO4 |
72599-27-0 |
| |
|
miriplatinum |
|
miriplatin |
(SP-4-2)-[(1R,2R)-cyclohexane-1,2-diamine-N,N] = bis(tetradecanoato-O)platinum
antineoplastic |
miriplatine |
(SP-4-2)-[(1R,2R)-cyclohexane-1,2-diamine-N,N] = bis(tétradécanoato-O)platine
antinéoplasique |
miriplatino |
(SP-4-2)-[(1R,2R)-ciclohexano-1,2-diamina-N,N] = bis(tetradecanoato-O)platino
antineoplásico |
| |
C34H68N2O4Pt |
141977-79-9 |
| |
|
mirostipenum |
|
mirostipen |
[23-methionine]human myeloid progenitor inhibitory factor 1-(23-99)-peptide
myeloprotectant |
mirostipen |
[23-méthionine]facteur 1 d’inhibition du précurseur myéloïde humain-(23-99)-peptide
protecteur des cellules hématopoiétiques |
mirostipeno |
[23-metionina]-(23-99)-péptido del factor 1 de inhibición del progenitor mieloidehumano
mieloprotector |
| |
C380H614N112O113S9 |
244130-01-6 |
| |
|
mureletecanum |
|
mureletecan |
poly[[N-(2-hydroxypropyl)methacrylamide]-co-[camptothecin ester with N-[6-(2-methacrylamidoacetamido)hexanoyl]glycine]-co-[N-[[(2-hydroxypropyl)carbamoyl]methyl]methacrylamide]]
antineoplastic |
murélétécan |
copolymère de N-[(2RS)-2-hydroxypropyl]-2-méthylpropénamide, de N-[2-[[6-[[2-[[(4S)-4-éthyl-3,14-dioxo-3,4,12,14-tétrahydro-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoléin-4-yl]oxy]-2-oxoéthyl]amino]-6-oxohexyl]amino]-2-oxoéthyl]-2-méthylpropénamide et de N-[2-[[(2RS)-2-hydroxypropyl]amino]-2-oxoéthyl]-2-méthylpropénamide
antinéoplasique |
mureletecán |
poli[[N-(2-hidroxipropil)metacrilamida]-co-[éster de camptotecina con N-[6-(2-metacrilamidoacetamido)hexanoil]glicina]-co-[N-[[(2-hidroxipropil)carbamoil]metil]metacrilamida]]
antineoplásico |
| |
|
nasaruplasum beta |
|
nasaruplase beta |
prourokinase (enzyme-activating) human (clone pUK4/pUK18 protein moiety), glycosylated (murine cell line SP2/0)
enzyme |
nasaruplase bêta |
prourokinase (activateur d’enzyme) humaine glycosylée dont le gène est cloné dans le vecteur pUK4/pUK18 et exprimée dans la lignée cellulaire murine SP2/0
enzyme |
nasaruplasa beta |
prourokinasa (activador de enzima) (fracción proteíca obtenida del clon humano pUK4/pUK18), glicosilada
enzima |
| |
C2031H3121N585O601S31 |
136653-69-5 |
| |
|
netoglitazonum |
|
netoglitazone |
(5RS)-5-[[6-[(2-fluorophenyl)methoxy]naphthalen-2-yl]methyl]thiazolidine-2,4-dione
antidiabetic |
nétoglitazone |
(5RS)-5-[[6-[(2-fluorophényl)méthoxy]naphtalén-2-yl]méthyl]thiazolidine-2,4-dione
antidiabétique |
netoglitazona |
(5RS)-5-[[6-[(2-fluorofenil)metoxi]naftalen-2-il]metil]tiazolidina-2,4-diona
antidiabético |
| |
C21H16FNO3S |
161600-01-7 |
| |
|
ospemifenum |
|
ospemifene |
2-[p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]phenoxy]ethanol
antiestrogen |
ospémifène |
(Z)-2-[4-(4-chloro-1,2-diphénylbut-1-ényl)phénoxy]éthanol
anti strogène |
ospemifeno |
2-[p-[(Z)-4-cloro-1,2-difenil-1-butenil]fenoxi]etanol
antiestrógeno |
| |
C24H23ClO2 |
128607-22-7 |
| |
|
pegfilgrastimum |
|
pegfilgrastim |
N-(3-hydroxypropyl)methionylcolony-stimulating factor (human), 1-ether with α-methyl-ω-hydroxypoly(oxyethylene)
immunomodulator |
pegfilgrastim |
N-(3-hydroxypropyl)méthionylfacteur de stimulation de colonie humain, 1-éther avec le α-méthyl-ω-hydroxypoly(oxyéthylène)
immunomodulateur |
pegfilgrastim |
N-(3-hydroxypropyl)methionyl(human colony-stimulating factor), 1-ether with α-methyl-ω-hydroxypoly(oxy-1,2-ethanediyl)
inmunomodulador |
| |
C849H1348N223O244S9,(C2H4O)n |
208265-92-3 |
| |
|
pexelizumabum |
|
pexelizumab |
immunoglobulin, anti-(human complement C5 α-chain) (human-mouse monoclonal 5G1.1-SC single chain)
immunomodulator |
pexélizumab |
immunoglobuline, anti-(chaîne-α du complément C5 humain) (mono chaîne de l’anticorps monoclonal de souris humanisé 5G1.1-SC)
immunomodulateur |
pexelizumab |
inmunoglobulina, anti-(cadena-αα de complemento C5 humano) (mono cadena del anticuerpo monoclonal humanizado de ratón 5G1.1-SC)
inmunomodulador |
| |
219685-93-5 |
pralnacasanum |
|
pralnacasan |
(1S,9S)-N-[(2R,3S)-2-ethoxy-5-oxotetrahydrofuran-3-yl]-9-[(isoquinolin-1-ylcarbonyl)amino]-6,10-dioxooctahydro-6-H-pyridazino[1,2-a][1,2] = diazepine-1-carboxamide
enzyme |
pralnacasan |
(1S,9S)-N-[(2R,3S)-2-éthoxy-5-oxotétrahydrofuran-3-yl]-9-[(isoquinoléin-1-ylcarbonyl)amino]-6,10-dioxooctahydro-6-H-pyridazino[1,2-a] = [1,2]diazépine-1-carboxamide
enzyme |
pralnacasán |
(1S,9S)-N-[(2R,3S)-2-etoxi-5-oxotetrahidrofuran-3-il]-9-[(isoquinolin-1-ilcarbonil)amino]-6,10-dioxooctahidro-6-H-piridazino[1,2-a][1,2]diazepina-1-carboxamida
enzima |
| |
C26H29N5O7 |
192755-52-5 |
| |
|
pratosartanum |
|
pratosartan |
2-propyl-3-[[2’-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-5,6,7,8-tetrahydrocycloheptaimidazol-4(3H)-one
angiotensin II receptor antagonist |
pratosartan |
2-propyl-3-[[2’-(1H-tétrazol-5-yl)biphényl-4-yl]méthyl]-5,6,7,8-tétrahydrocycloheptaimidazol-4(3H)-one
antagoniste du récepteur de l’angiotensine II |
pratosartán |
2-propil-3-[[2’-(1H-tetrazol-5-il)bifenil-4-il]metil]-5,6,7,8-tetrahidrocicloheptaimidazol-4(3H)-ona
antagonista del receptor de angiotensina II |
| |
C25H26N6O |
153804-05-8 |
| |
|
ragaglitazarum |
|
ragaglitazar |
(-)-(2S)-2-ethoxy-3-[4-[2-(10H-phenoxazin-10-yl)ethoxy]phenyl]propanoic acid
antidiabetic |
ragaglitazar |
(-)-acide (2S)-2-éthoxy-3-[4-[2-(10H-phénoxazin-10-yl)éthoxy]phényl] = propanoïque
antidiabétique |
ragaglitazar |
(-)-ácido (2S)-2-etoxi-3-[4-[2-(10H-fenoxazin-10-il)etoxi]fenil]propanoico
antidiabético |
| |
C25H25NO5 |
222834-30-2 |
| |
|
reminertantum |
|
reminertant |
2-[[[1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-3-yl]carbonyl]amino]tricyclo[3.3.1.13,7]decane-2-carboxylic acid
neurotensin antagonist |
réminertant |
acide 2-[[[1-(7-chloroquinoléin-4-yl)-5-(2,6-diméthoxyphényl)-1H-pyrazol-3-yl]carbonyl]amino]tricyclo[3.3.1.13,7]décane-2-carboxylique
antagoniste de la neurotensine |
reminertant |
ácido 2-[[[1-(7-cloroquinolin-4-il)-5-(2,6-dimetoxifenil)-1H-pirazol-3-il]carbonil]amino]triciclo[3.3.1.13,7]decano-2-carboxílico
antagonista de la neurotensina |
| |
C32H31ClN4O5 |
146362-70-1 |
| |
|
reslizumabum |
|
reslizumab |
immunoglobulin G4, anti-(human interleukin 5) (human-rat monoclonal SCH 55700 γ4-chain), disulfide with human-rat monoclonal SCH 55700 light chain, dimer
immunomodulator |
reslizumab |
immunoglobuline G4, anti-(interleukine 5 humaine), (chaîne γ4 de l’anticorps monoclonal de rat humanisé SCH 55700), dimère du disulfure avec la chaîne légère de l’anticorps monoclonal de rat humanisé SCH 55700
immunomodulateur |
reslizumab |
immunoglobulina G4, anti-(interleukina 5 humana), (cadena γ4 del anticuerpo monoclonal humanizado de rata SCH 55700), dímero del disulfuro con la cadena ligera del anticuerpo monoclonal humanizado de rata SCH 55700
inmunomodulador |
| |
241473-69-8 |
ruboxistaurinum |
|
ruboxistaurin |
(9S)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,19H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-18,20-dione
PKC â inhibitor |
ruboxistaurine |
(9S)-9-[(diméthylamino)méthyl]-6,7,10,11-tétrahydro-9H,19H-5,21:12,17-diméthénodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadécène-18,20-dione
inhibiteur de l’isoforme β de la protéinekinase C |
ruboxistaurina |
(9S)-9-[(dimetilamino)metil]-6,7,10,11-tetrahidro-9H,19H-5,21:12,17-dimetenodibenzo[e,k]pirrolo[3,4-h][1,4,13]oxadiazaciclohexadeceno-18,20-diona
inhibidor de la PKC |
| |
C28H28N4O3 |
169939-94-0 |
| |
|
semaxanibum |
|
semaxanib |
3-[(Z)-(3,5-dimethylpyrrol-2-yl)methylene]-2-indolinone
antineoplastic |
sémaxanib |
(Z)-3-[(3,5-diméthyl-1H-pyrrol-2-yl)méthylène]-1,3-dihydro-2H-indol-2-one
antinéoplasique |
semaxanib |
3-[(Z)-(3,5-dimetilpirrol-2-il)metileno]-2-indolinona
antineoplásico |
| |
C15H14N2O |
194413-58-6 |
| |
|
senazodanum |
|
senazodan |
6-[4-(pyridin-4-ylamino)phenyl]-4,5-dihydropyridazin-3(2H)-one
cardiac stimulant |
sénazodan |
6-[4-(pyridin-4-ylamino)phényl]-4,5-dihydropyridazin-3(2H)-one
cardiotonique |
senazodán |
6-[4-(piridin-4-ilamino)fenil]-4,5-dihidropiridazin-3(2H)-ona
cardiotónico |
| |
C15H14N4O |
98326-32-0 |
| |
|
silodosinum |
|
silodosin |
(-)-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy] = ethyl]amino]propyl]-2,3-dihydro-1H-indole-7-carboxamide
á1a-adrenoreceptor antagonist |
silodosine |
(-)-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroéthoxy)phénoxy] = éthyl]amino]propyl]-2,3-dihydro-1H-indole-7-carboxamide |
| |
antagonisteá1a-adrénergique |
silodosina |
(-)-1-(3-hidroxipropil)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroetoxi)fenoxi]etil] = amino]propil]-2,3-dihidro-1H-indol-7-carboxamida
antagonista de los receptores á1a-adrenérgicos |
| |
C25H32F3N3O4 |
160970-54-7 |
| |
|
solifenacinum |
|
solifenacin |
(3R)-1-azabicyclo[2.2.2]oct-3-yl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate
muscarin receptor antagonist |
solifénacine |
(1S)-1-phényl-3,4-dihydroisoquinoléine-2(1H)-carboxylate de (3R)-1-azabicyclo[2.2.2]oct-3-yle
antagoniste des récepteurs de la muscarine |
solifenacina |
(1S)-1-fenil-3,4-dihidroisoquinolina-2(1H)-carboxilato de(3R)-1-azabiciclo[2.2.2]oct-3-ilo |
| |
antagonista de los receptores de la muscarinicos |
| |
C23H26N2O2 |
242478-37-1 |
| |
|
tadalafilum |
|
tadalafil |
(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1’,2’:1,6]pyrido[3,4-b]indole-1,4-dione
vasodilator |
tadalafil |
(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-méthyl-2,3,6,7,12,12a-hexahydropyrazino[1’,2’:1,6]pyrido[3,4-b]indole-1,4-dione
vasodilateur |
tadalafilo |
(6R,12aR)-6-(1,3-benzodioxol-5-il)-2-metil-2,3,6,7,12,12a-hexahidropirazino[1’,2’:1,6]pirido[3,4-b]indol-1,4-diona
vasodilatador |
| |
C22H19N3O4 |
171596-29-5 |
| |
|
tafluposidum |
|
tafluposide |
4-[(5R,5aR,8aR,9S)-9-[[4,6-O-[(1R)-ethylidene]-2,3-bisO-[(pentafluorophenoxy)acetyl]-β-D-glucopyranosyl]oxy]-6-oxo-5,5a,6,8,8a,9-hexahydrofuro[3’,4’:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]-2,6-dimethoxyphenyle dihydrogen phosphate
cytostatic |
tafluposide |
dihydrogénophosphate de 4-[(5R,5aR,8aR,9S)-9-[[4,6-O-[(1R)-éthylidène]-2,3-bisO-[(pentafluorophénoxy)acétyl]-β-D-glucopyranosyl]oxy]-6-oxo-5,5a,6,8,8a,9-hexahydrofuro[3’,4’:6,7]naphto[2,3-d]-1,3-dioxol-5-yl]-2,6-diméthoxyphényle
cytostatique |
taflupósido |
dihidrógenofosfato de 4-[(5R,5aR,8aR,9S)-9-[[4,6-O-[(1R)-etilideno]-2,3-bisO-[(pentafluorofenoxi)acetil]-β-D-glucopiranosil]oxi]-6-oxo-5,5a,6,8,8a,9-hexahidrofuro[3’,4’:6,7]nafto[2,3-d]-1,3-dioxol-5-il]-2,6-dimetoxifenilo
citostático |
| |
C45H35F10O 20P |
179067-42-6 |
| |
|
telberminum |
|
telbermin |
vascular endothelial growth factor (human), dimer
angiogene |
telbermine |
facteur de croissance de l’endothélium vasculaire humain (dimère)
angiogène |
telbermina |
factor de crecimiento del endotelio vascular (humano), dímero
factor angiogénico |
| |
C1612H2536N500O498S44 |
205887-54-3 |
| |
|
tenivastatinum |
|
tenivastatin |
(3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphtalen-1-yl]-3,5-dihydroxyheptanoic acid
antihyperlipidaemic |
ténivastatine |
acide (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-diméthylbutanoyl)oxy]-2,6-diméthyl-1,2,6,7,8,8a-hexahydronaphtalén-1-yl]-3,5-dihydroxyheptanoïque
antihyperlipidémiant |
tenivastatina |
ácido (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-dimetilbutanoil)oxi]-2,6-dimetil-1,2,6,7,8,8a-hexahidronaftalen-1-il]-3,5-dihidroxiheptanoico
antihiperlipémico |
| |
C25H40O6 |
121009-77-6 |
| |
|
tesaglitazarum |
|
tesaglitazar |
(2S)-2-ethoxy-3-[4-[2-[4-[(methylsulfonyl)oxy]phenyl]ethoxy]phenyl] = propanoic acid
antidiabetic |
tésaglitazar |
acide (2S)-2-éthoxy-3-[4-[2-[4-[(méthylsulfonyl)oxy]phényl]éthoxy]phényl] = propanoïque
antidiabétique |
tesaglitazar |
ácido (2S)-2-etoxi-3-[4-[2-[4-[(metilsulfonil)oxi]fenil]etoxi]fenil]propanoico
antidiabético |
| |
C20H24O7S |
251565-85-2 |
| |
|
tofimilastum |
|
tofimilast |
9-cyclopentyl-7-ethyl-3-(thiophen-2-yl)-6,9-dihydro-5H-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a]pyridine
antiasthmatic |
tofimilast |
9-cyclopentyl-7-éthyl-3-(thiophén-2-yl)-6,9-dihydro-5H-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a]pyridine
antiasthmatique |
tofimilast |
9-ciclopentil-7-etil-3-(tiofen-2-il)-6,9-dihidro-5H-pirazolo[3,4-c]-1,2,4-triazolo[4,3-a]piridina
antiasmático |
| |
C18H21N5S |
185954-27-2 |
| |
|
xidecaflurum |
|
xidecaflur |
2,2-[(9Z)-9-octadecenylimino]diethanol hydrofluoride
dental product, anticaries |
xidécaflur |
fluorhydrate de 2,2-[(9Z)-octadec-9-énylimino]diéthanol
prophylaxie des caries dentaires |
xidecaflur |
hidrofluoruro de 2,2-[(9Z)-9-octadecenilimino]dietanol
producto dental anticaries |
| |
C22H46FNO2 |
207916-33-4 |
| |
|
zanapezilum |
|
zanapezil |
3-(1-benzylpiperidin-4-yl)-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)propan-1-one
nootropic agent |
zanapézil |
3-(1-benzylpipéridin-4-yl)-1-(2,3,4,5-tétrahydro-1H-1-benzazépin-8-yl)propan-1-one
nootrope |
zanapezilo |
3-(1-bencilpiperidin-4-il)-1-(2,3,4,5-tetrahidro-1H-1-benzazepin-8-il)propan-1-ona
nootropo |
| |
C25H32N2O |
142852-50-4 |
| |
|
zonampanelum |
|
zonampanel |
[7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydroquinoxalin-1(2H)-yl]acetic acid
AMPA receptor antagonist |
zonampanel |
acide [7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydroquinoxalin-1(2H)-yl]acétique
antagoniste des récepteurs de l’AMPA |
zonampanel |
ácido [7-(1H-imidazol-1-il)-6-nitro-2,3-dioxo-3,4-dihidroquinoxalin-1(2H)-il]acético
antagonista de los receptores de AMPA |
| |
C13H9N5O6 |
210245-80-0 |
| |
|
zoniporidum |
|
zoniporide |
N-carbamimidoyl-5-cyclopropyl-1-(quinolin-5-yl)-1H-pyrazole-4-carboxamide
Na+/H+ antiport inhibitor |
zoniporide |
N-carbamimidoyl-5-cyclopropyl-1-(quinoléin-5-yl)-1H-pyrazole-4-carboxamide |
| |
inhibiteur de l’échange Na+/H+ |
zoniporida |
N-carbamimidoil-5-ciclopropil-1-(quinolin-5-il)-1H-pyrazol-4-carboxamida
inhibidor del transporte activo Na+/H+ |
| |
C17H16N6O |
241800-98-6 |
| |
|
zoticasonum |
|
zoticasone |
S-[(3R)-2-oxotétrahydrofuran-3-yl] 6á,9-difluoro-12â,17-dihydroxy-16á-methyl-3-oxoandrosta-1,4-diene-17â-carbothioate
corticosteroid |
zoticasone |
6á,9-difluoro-12â,17-dihydroxy-16á-méthyl-3-oxoandrosta-1,4-diène-17â-carbothioate de S-[(3R)-2-oxotétrahydrofuran-3-yle]
corticostéroïde |
zoticasona |
6á,9-difluoro-12â,17-dihidroxi-16á-metil-3-oxoandrosta-1,4-dieno-17â-carbotioato de S-[(3R)-2-oxotetrahidrofuran-3-ilo]
corticosteroide |
| |
C25H30F2O6S |
| |
|
Loading...
